Search Results - "Segnan, N."

Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

Authors: Segnan N Armaroli P Bonelli L et al.

Source: JNCI: Journal of the National Cancer Institute. Sep2011, Vol. 103 Issue 17, p1310-1322. 13p.

Baseline findings of the Italian multicenter randomized controlled trial of "once-only sigmoidoscopy"--SCORE.

Authors: Segnan N Senore C Andreoni B et al.

Source: JNCI: Journal of the National Cancer Institute. 12/4/2002, Vol. 94 Issue 23, p1763-1772. 10p.

European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication.

Authors: von Karsa, L. Patnick, J. Segnan, N. et al.

Source: Endoscopy. Jan2013, Vol. 45 Issue 1, p51-59. 9p.

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Executive summary.

Authors: Von Karsa, L. Patnick, J. Segnan, N.

Source: Endoscopy. 2012 Supplement 2, Vol. 44, pSE1-SE8. 8p.

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Principles of evidence assessment and methods for reaching recommendations.

Authors: Minozzi, S. Armaroli, P. Segnan, N.

Source: Endoscopy. 2012 Supplement 2, Vol. 44, pSE9-SE14. 6p.

Baldness and testicular cancer: the EPSAM case-control study.

Authors: Moirano, G. Zugna, D. Grasso, C. et al.

Source: Andrology. Mar2016, Vol. 4 Issue 2, p251-256. 6p.

Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction.

Authors: Puliti, D. Miccinesi, G. Collina, N. et al.

Source: British Journal of Cancer. 8/5/2008, Vol. 99 Issue 3, p423-427. 5p. 2 Charts.

Do women >or=50 years of age need as much screening as women <50 years after they have had negative screening results?

Authors: Armaroli, P Gallo, F Bellomi, A et al.

Source: British Journal of Cancer. 7/22/2008, Vol. 99 Issue 2, p239-244. 6p. 6 Charts, 1 Graph.

Effect of circulation and discussion of cervical smears on agreement between laboratories.

Authors: Ronco, G. Montanari, G. Confortini, M. et al.

Source: Cytopathology. Jun2003, Vol. 14 Issue 3, p115-120. 6p.

Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing.

Authors: Carozzi, F Ronco, G Confortini, M et al.

Source: British Journal of Cancer. 12/1/2000, Vol. 83 Issue 11, p1462. 6p.

Impact of the introduction of organised screening for cervical cancer in Turin, Italy: cancer incidence by screening history 1992-98.

Authors: Ronco, G. Pilutti, S. Patriarca, S. et al.

Source: British Journal of Cancer. 8/8/2005, Vol. 93 Issue 3, p376-378. 3p.

Cervical screening according to age and HPV status: cytological screening under age 25 has never low effectiveness; after that HPV genotyping helps to stratify risk.

Authors: Ronco G Arbyn M Segnan N

Source: BMJ: British Medical Journal (Overseas & Retired Doctors Edition). 8/8/2009, Vol. 339 Issue 7716, pb3005-b3005. 1p.

A phase-III prevention trial of low-dose tamoxifen in postmenopausal hormone replacement therapy users: the HOT study.

Authors: DeCensi, A. Bonanni, B. Maisonneuve, P. et al.

Source: Annals of Oncology. Nov2013, Vol. 24 Issue 11, p2753-2760. 8p. 3 Charts, 2 Graphs.

Stratified Cancer Screening: The Practicalities of Implementation.

Authors: Dent, T. Jbilou, J. Rafi, I. et al.

Source: Public Health Genomics. May2013, Vol. 16 Issue 3, p94-99. 6p. 1 Diagram.

European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition Colonoscopic surveillance following adenoma removal.

Authors: Atkin, W. S. Valori, R. Kuipers, E. J. et al.

Source: Endoscopy. 2012 Supplement 2, Vol. 44, pSE151-SE163. 13p.

Screening for cervical cancer.

Authors: Ronco G Meijer CJ Cuzick J et al.

Source: Annals of Internal Medicine. 4/17/2012, Vol. 156 Issue 8, p604-606. 4p.

Assessment of the multiple components of the variability in the adenoma detection rate in sigmoidoscopy screening, and lessons for training.

Authors: Fracchia M Senore C Armaroli P et al.

Source: Endoscopy. Jun2010, Vol. 42 Issue 6, p448-455. 8p.

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary Document.

Authors: Arbyn, M. Anttila, A. Jordan, J. et al.

Source: Annals of Oncology. Mar2010, Vol. 21 Issue 3, p448-458. 11p. 4 Charts.

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTTCC randomised controlled trial.

Authors: Carozzi F Confortini M Palma PD et al.

Source: Lancet Oncology. Oct2008, Vol. 9 Issue 10, p937-945. 9p.

Correspondence.

Authors: Robbins AS Clarke CA Anderson BO et al.

Source: JNCI: Journal of the National Cancer Institute. 12/5/2007, Vol. 99 Issue 23, p1815-1819. 5p.